229 related articles for article (PubMed ID: 22367268)
61. The use of focus groups to characterize symptoms in persons with multiple sclerosis.
Newland PK; Thomas FP; Riley M; Flick LH; Fearing A
J Neurosci Nurs; 2012 Dec; 44(6):351-7. PubMed ID: 23124125
[TBL] [Abstract][Full Text] [Related]
62. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.
Kroencke DC; Lynch SG; Denney DR
Mult Scler; 2000 Apr; 6(2):131-6. PubMed ID: 10773860
[TBL] [Abstract][Full Text] [Related]
63. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
64. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
Wolkorte R; Heersema DJ; Zijdewind I
Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
[TBL] [Abstract][Full Text] [Related]
65. Longitudinal change in physical activity and its correlates in relapsing-remitting multiple sclerosis.
Motl RW; McAuley E; Sandroff BM
Phys Ther; 2013 Aug; 93(8):1037-48. PubMed ID: 23599354
[TBL] [Abstract][Full Text] [Related]
66. Chronic pain and the development of a symptom checklist: a pilot study.
Kendall S; Holm NR; Højsted J; Frich L; Rotbøll Nielsen P; Jensen NH; Sjøgren P
Acta Anaesthesiol Scand; 2013 Aug; 57(7):920-8. PubMed ID: 23750563
[TBL] [Abstract][Full Text] [Related]
67. An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Day MA; Ehde DM; Ward LC; Hartoonian N; Alschuler KN; Turner AP; Kraft GH; Jensen MP
Clin J Pain; 2016 Feb; 32(2):155-63. PubMed ID: 26741742
[TBL] [Abstract][Full Text] [Related]
68. [Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level].
Tyburski E; Potemkowski A; Cheć M; Sołtys A; Mak M; Samochowiec A
Psychiatr Pol; 2014; 48(2):307-18. PubMed ID: 25016768
[TBL] [Abstract][Full Text] [Related]
69. Symptom clusters in children.
Rodgers CC; Hooke MC; Hockenberry MJ
Curr Opin Support Palliat Care; 2013 Mar; 7(1):67-72. PubMed ID: 23108342
[TBL] [Abstract][Full Text] [Related]
70. Primary care management of fatigue and relapses in RRMS.
Oliver BJ
Nurse Pract; 2009 Sep; 34(9):10-4. PubMed ID: 19713814
[No Abstract] [Full Text] [Related]
71. Tracking daily fatigue fluctuations in multiple sclerosis: ecological momentary assessment provides unique insights.
Powell DJH; Liossi C; Schlotz W; Moss-Morris R
J Behav Med; 2017 Oct; 40(5):772-783. PubMed ID: 28281106
[TBL] [Abstract][Full Text] [Related]
72. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
Rasova K; Brandejsky P; Havrdova E; Zalisova M; Rexova P
Mult Scler; 2005 Apr; 11(2):213-21. PubMed ID: 15794397
[TBL] [Abstract][Full Text] [Related]
73. Chemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxel.
Golan-Vered Y; Pud D
Pain Pract; 2013 Jan; 13(1):46-52. PubMed ID: 22533683
[TBL] [Abstract][Full Text] [Related]
74. Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Etgen T; Adler-Hunklinger U; Hemmer B
Acta Neurol Belg; 2012 Sep; 112(3):307-9. PubMed ID: 22476976
[No Abstract] [Full Text] [Related]
75. Pain in women with relapsing-remitting multiple sclerosis and in healthy women: a comparative study.
Newland P
J Neurosci Nurs; 2008 Oct; 40(5):262-8. PubMed ID: 18856246
[TBL] [Abstract][Full Text] [Related]
76. [The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS)].
Leclercq E; Cabaret M; Guilbert A; Jougleux C; Vermersch P; Moroni C
Geriatr Psychol Neuropsychiatr Vieil; 2014 Sep; 12(3):331-8. PubMed ID: 25245320
[TBL] [Abstract][Full Text] [Related]
77. Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis.
Chang YT; Kearns PKA; Carson A; Gillespie DC; Meijboom R; Kampaite A; Valdés Hernández MDC; Weaver C; Stenson A; MacDougall N; O'Riordan J; Macleod MA; Carod-Artal FJ; Connick P; Waldman AD; Chandran S; Foley P
Mult Scler Relat Disord; 2023 Jan; 69():104429. PubMed ID: 36493562
[TBL] [Abstract][Full Text] [Related]
78. Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Penner IK; Hubacher M; Rasenack M; Sprenger T; Weber P; Naegelin Y
Mult Scler; 2013 Mar; 19(3):366-8. PubMed ID: 22740487
[TBL] [Abstract][Full Text] [Related]
79. Sleep and fatigue following traumatic brain injury.
Ponsford JL; Sinclair KL
Psychiatr Clin North Am; 2014 Mar; 37(1):77-89. PubMed ID: 24529424
[TBL] [Abstract][Full Text] [Related]
80. End of dose interval symptoms in patients treated with natalizumab: A role for serum cytokines?
Cathérine D; Annelien P; Anne S; Luc A; Liesbeth VH; Gerlo S; Guy L
Mult Scler Relat Disord; 2020 Jun; 41():102020. PubMed ID: 32146430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
